Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$1.98 +0.17 (+9.39%)
At close: Nov 12, 2026 · 4:00 PM EST

Harvard Apparatus Regenerative Technology (HRGN) Construction in Progress (2016)

Updated

Harvard Apparatus Regenerative Technology (HRGN) posted Construction in Progress of $108,000 for Q4 2016.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Construction in Progress (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Harvard Apparatus Regenerative Technology 2.32 Mn -1.70 Mn 12,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 108,000.00
API Access

Harvard Apparatus Regenerative Technology Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=HRGN&period=max&api_key=YOUR_API_KEY